False-negative results can occur with undetected mild hypercortisolemia or in the early stages of endocrinopathy, when the adrenal tumor does not exhibit corticotropin receptors, or through pre-analytical errors (Melián, 2017). Here, MC2R is linked to endocrine system disorder.